External beam radiotherapy for localized prostate cancer

External beam radiotherapy for localized prostate cancer

Radiotherapy (XRT) is a curative treatment option for prostate cancer (PCa). Recent XRT technologies allow higher dose therapy that lead to increased local control with less adjacent tissue damage. Additionally, receiving neo-adjuvant or adjuvant hormonotherapy (HT) during radiation therapy increase...

Full description

Bibliographic Details
Main Authors:	Hasan Yilmaz, Gorkem Aksu, Ozdal Dillioglugil
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Series:	Asian Journal of Andrology
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=6;spage=892;epage=898;aulast=Yilmaz

Similar Items

Seminal Vesicle Treatment for Localized Prostate Cancer Treated with External Beam Radiotherapy
by: Tanner Steed, et al.
Published: (2023-07-01)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
by: Jeong Hoon Phak, et al.
Published: (2016-03-01)

DOSE-ESCALATED EXTERNAL BEAM RADIOTHERAPY DURING HORMONO-RADIOTHERAPY FOR PROSTATE CANCER
by: Yu. V. Gumenetskaya, et al.
Published: (2016-07-01)

Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy
by: Paulo Costa, et al.
Published: (2024-03-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
by: Eileen Samuel, et al.
Published: (2024-02-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
by: Vanessa Di Lalla, et al.
Published: (2022-11-01)

Comparing prognosis of external beam radiotherapy versus radical prostatectomy for patients with prostate cancer
by: Cai Tang, et al.
Published: (2024-04-01)

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
by: Wu, X, et al.
Published: (2019)

Effects of gold fiducial marker implantation on tumor control and toxicity in external beam radiotherapy of prostate cancer
by: Moll Matthias, et al.
Published: (2023-01-01)

Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15)
by: Seo Hee Choi, et al.
Published: (2021-05-01)

Updates on Radiotherapy for Localized Prostate Cancer
by: Alexandros Papachristofilou
Published: (2023-12-01)

Outcomes and complications of intraoperative radiotherapy versus external beam radiotherapy for early breast cancer
by: Vahid Zangouri, et al.
Published: (2024-02-01)

Efficacy and Safety of High-Dose-Rate Brachytherapy of Single Implant with Two Fractions Combined with External Beam Radiotherapy for Hormone-Naïve Localized Prostate Cancer
by: Yasutaka Noda, et al.
Published: (2011-09-01)

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
by: Matthew Richardson, et al.
Published: (2018-05-01)

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
by: Marcin Miszczyk, et al.
Published: (2022-02-01)

Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
by: Berdine L. Heesterman, et al.
Published: (2023-05-01)

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
by: R Miralbell, et al.
Published: (2009-09-01)

Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer
by: Shuichi Nishimura, et al.
Published: (2018-05-01)

Diameter discrepancy and treatment accuracy in external beam radiotherapy
by: Moghaddam Ghanbar Behnaz, et al.
Published: (2012-01-01)

Adjuvant External Beam Radiotherapy with Concurrent Cisplatin after Resection of Gallbladder Cancer
by: Sunil Choudhary, et al.
Published: (2019-02-01)

External beam radiotherapy and intracavitary brachytherapy is an acceptable treatment for locally advanced carcinoma of the uterine cervix
by: Md. Zillur Rahman Bhuiyan, et al.
Published: (2016-08-01)

Clinical outcomes after salvage external beam radiotherapy combined with interstitial brachytherapy for locally advanced, recurrent endometrial cancer
by: Asmara Waheed, et al.
Published: (2023-03-01)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
by: Hideya Yamazaki, et al.
Published: (2021-12-01)

External Beam Radiotherapy for Dysphagia Palliation in Advanced Esophageal Cancer: A Prospective Study
by: Abhinandan Das, et al.
Published: (2023-11-01)

Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer
by: Andries H Groen, et al.
Published: (2023-01-01)

Bilateral Rhegmatogenous Retinal Detachment during External Beam Radiotherapy
by: Takako Hidaka, et al.
Published: (2016-06-01)

Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia
by: Wempy Supit
Published: (2013-03-01)

Salvage high-dose-rate interventional radiotherapy (brachytherapy) for locally relapsed prostate cancer after radical prostatectomy and subsequent external irradiation
by: Tamer Soror, et al.
Published: (2023-06-01)

Reporting perioperative complications of radical cystectomy: the influence of using standard methodology based on ICARUS and EAU quality criteria
by: Naci Burak Cinar, et al.
Published: (2023-02-01)

Open retropubic radical prostatectomy versus external beam radiation therapy for localized prostate cancer - patient-reported outcomes
by: Bašić Dragoslav, et al.
Published: (2023-01-01)

Revolutionizing localized prostate cancer treatment: Stereotactic radiotherapy “Moroccan experience”
by: Asmâa Naim, et al.
Published: (2024-02-01)

External beam radiotherapy in high-risk head-and-neck cancers with reduced overall treatment time in telecobalt beam quality
by: Ramamoorthy Ravichandran, et al.
Published: (2023-01-01)

Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer
by: Nina Samson, et al.
Published: (2021-09-01)

Pencil Beam Scanning Proton Bragg Peak Conformal FLASH in Prostate Cancer Stereotactic Body Radiotherapy
by: Tyler Kaulfers, et al.
Published: (2024-02-01)

Fabrication Of Rhizophora Spp. Head Phantom For External Beam Radiotherapy Applications
by: Zuber, Siti Hajar
Published: (2022)

External Beam Radiotherapy of Recurrent Glioma: Radiation Tolerance of the Human Brain
by: Peter Sminia, et al.
Published: (2012-04-01)

Errors detected during physics plan review for external beam radiotherapy
by: Frank-André Siebert, et al.
Published: (2022-10-01)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
by: Hun Jung Kim, et al.
Published: (2015-12-01)